Meeting Notice - North Dakota Medicaid Drug Use Review Board (Dec. 2, 2026)

North Dakota Medicaid Drug Use Review Board
Wednesday, Dec. 2, 2026
1-4 p.m. CT

In-person Information

HHS Hoteling Space, Room 308, State Capitol
600 E. Boulevard Ave., Bismarck ND, 58505

Virtual Information

Join by computer: Join the virtual meeting
Join by phone: 701-328-0950, Conference ID 288 179 943 233 45

Agenda

• Agenda
• Call to Order
• Roll Call
• Review and Approval of Minutes
• Reports from Department
• Administrative Report: PDMP data
• Financial Report
• Retrospective Drug Utilization Review (DUR) Report
• Clinical Report
  • Prior Authorization and Criteria Updates: Anti-infectives/Anti-inflammatories – Fluroquinolones, Asthma/COPD, Cholestatic Pruritis, Diabetes, Diabetic Kidney Disease, Heart Failure, Hepatitis C Antiviral Treatments, Hypertrophic Cardiomyopathy, Lipid-Lowering Medication, Migraine, Spinal Muscular Atrophy, Systemic Lupus Erythematosus
  • Annual Prior Authorization Review
• Unfinished Business – Nausea and Vomiting Criteria, Updated financial charts form Q3 meeting
• New Business
• Second Reviews of Antipsychotics, Human Immunodeficiency Virus, Human Coronavirus, Hypertension, Long-acting Opioids, Pheochromocytoma
• First Reviews of Contraceptives, Fibrodysplasia ossificans progressiva (FOP)
• Brand Antipsychotic Report Card
• Review of Retrospective DUR Criteria Recommendations
• Provider suggestions for clinical practice education or Retrospective Drug Utilization Review (RDUR) Incremental Cost-Effectiveness Ratio (ICER) criteria
• Announcements: Next Meeting (March 3, 2027)
• Adjourn

Individuals who need accommodations in order to participate or who would like information about joining the meeting can contact Ashley Gerving at 701-328-2354, 711 (TTY) or gervingashley@nd.gov.

Date Posted: Dec. 2, 2025 
Date Revised: Nov. 4, 2026 (agenda/meeting details added)